Clinical & translational oncology

• 

  Año 2016, Vol. 18, Número 6 (June 2016)

  • Review Article

    • Inhibiting the PI3K signaling pathway: buparlisib as a new targeted option in breast carcinoma

      Laura G. García Estévez, Elena García García, Manuel Hidalgo Medina

      • Resumen

      págs. 541-549

      

    • Molecular biology of testicular germ cell tumors

      R. Gonzalez Exposito, M. Merino, C. Aguayo

      • Resumen

      págs. 550-556

      

  • Clinical Guides in Oncology

    • Management of infection and febrile neutropenia in patients with solid cancer

      Juan Antonio Virizuela Echaburu, Jordi Carratalà Fernández, José María Aguado García, David Vicente Baz, Miguel Salavert Lletí, M. Ruiz, Isabel Ruiz Camps, Francesc Marco, Manuel Lizasoain, P. Jiménez Fonseca, C. Gudiol, Javier Cassinello Espinosa, Alberto Carmona Bayonas, Manuela Aguilar Guisado, Juan Jesús Cruz Hernández

      • Resumen

      págs. 557-570

      

  • Research Article

    • Concurrent chemo-radiotherapy in elderly patients: tolerance and compliance in a series of 137 patients

      M. Di Genesio Pagliuca, C. Perotti, G. Apicella, A. Galla, M. Guffi, M. Paolini, L. Donis, V. Amisano, S. Torrente, I. Manfredda, Marco Krengli

      • Resumen

      págs. 571-575

      

    • Dual inhibiting EGFR and VEGF pathways versus EGFR-TKIs alone in the treatment of advanced non-small-cell lung cancer: a meta-analysis of randomized controlled trials

      T. T. Zhang, R. M. Wang, Z. Yang, G. B. Chen

      • Resumen

      págs. 576-581

      

    • The position and current status of radiation therapy after primary systemic therapy in breast cancer: a national survey-based expert consensus statement

      Meritxell Arenas Prat, Angel Montero, Mª Dolores de las Peñas Cabrera, Manuel Ignacio Algara López

      • Resumen

      págs. 582-591

      

    • The relation of EGFR expression by immunohistochemical staining and clinical response of combination treatment of nimotuzumab and chemotherapy in esophageal squamous cell carcinoma

      Jun Jia, Y. Cui, M. Lu, Xiaoli Wang, Jie Li, Jian Li, Y. Li, X. Zhang, J. Gao, J. Zhou, Zhihao Lu, J. Gong, Jing Yu, Z. Sun, C. Liu, L. Shen, X. Zhang

      • Resumen

      págs. 592-598

      

    • Prognostic value of tropomyosin-related kinases A, B, and C in gastric cancer

      A. Kamiya, M. Inokuchi, S. Otsuki, H. Sugita, K. Kato, H. Uetake, K. Sugihara, Y. Takagi, K. Kojima

      • Resumen

      págs. 599-607

      

    • Prognostic importance of RASSF2 expression in patients with gastric cancer who had undergone radical gastrectomy

      D. Aydin, Ahmet Bilici, S. Kayahan, D. Yavuzer, M. Basar, Mehmet Aliustaoglu

      • Resumen

      págs. 608-616

      

    • The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients

      M. Ozcelik, H. Odabas, O. Ercelep, S. Yuksel, A. G. Mert, D. Aydin, H. Surmeli, D. Isik, S. Isik, A. Oyman, Basak Oven Ustaalioglu, Mehmet Aliustaoglu, Mahmut Gumus

      • Resumen

      págs. 617-624

      

    • Is c-Met oncoprotein expression an adverse prognosticator in extrahepatic bile duct cancer treated with curative resection followed by adjuvant chemoradiotherapy?

      H. J. Park, K Kim, J. H. Paik, Eui Kyu Chie, S. Kim, Jin Young Jang, Sun Whe Kim, Sae-Won Han, Do-Youn Oh, Seock-Ah Im, Tae-You Kim, Yung-Jue Bang, Sung W. Ha

      • Resumen

      págs. 625-631

      

    • Visceral obesity stimulates anaphase bridge formation and spindle assembly checkpoint dysregulation in radioresistant oesophageal adenocarcinoma

      A. M. Mongan, N. Lynam-Lennon, R. Casey, S. Maher, Graham P. Pidgeon, John V. Reynolds, J. O Sullivan

      • Resumen

      págs. 632-640

      

    • Effects of metformin on survival outcomes of lung cancer patients with type 2 diabetes mellitus: a meta-analysis

      R.-H. Tian, Y. G. Zhang, Z. Wu, X. Liu, J.-W. Yang, H.-L. Ji

      • Resumen

      págs. 641-649

      

  • Erratum

    • Erratum to: Autologous tumor lysate/Bacillus Calmette–Guérin immunotherapy as an adjuvant to conventional breast cancer therapy

      Jacinto Convit, H Montesinos, H. Oviedo, Gabriel Romero, B. Maccarone, E. Essenfeld, A. Convit, L. E Palacios

      págs. 650-650

      

    • Erratum to: Visceral obesity stimulates anaphase bridge formation and spindle assembly checkpoint dysregulation in radioresistant oesophageal adenocarcinoma

      A. M. Mongan, N. Lynam-Lennon, R. Casey, S. Maher, Graham P. Pidgeon, John V. Reynolds, J. O Sullivan

      págs. 651-651